会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Vascularization enhanced graft constructs
    • 血管化增强移植物构建体
    • US08084048B2
    • 2011-12-27
    • US12557176
    • 2009-09-10
    • Stephen F. Badylak
    • Stephen F. Badylak
    • A61K35/407A61K35/12
    • A61L27/3886A61K35/34A61L27/3604A61L27/3804A61L27/3808A61L27/3813A61L27/3826A61L27/383
    • A tissue graft construct for use in repairing diseased or damaged tissues is provided. The tissue graft construct comprises a matrix composition selected from the group consisting of liver basement membrane and extracts and hydrolysates thereof, and processed collagen from vertebrate non-submucosal sources, added endothelial cells, and at least one additional preselected, exogenous population of cells which enhance the initiation of vessel-like structures in the grant. The preselected population of cells can be a population of non-keratinized or keratinized epithelial cells or a population of mesodermally derived cells selected from the group consisting of fibroblasts, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, multi-potential progenitor cells, pericytes, osteogenic cells, and any other suitable cell type, preferably selected based on the tissue to be repaired. Methods for enhancing the vascularization in vivo of these tissue graft constructs and for preparing these graft constructs are also provided.
    • 提供了用于修复患病或受损组织的组织移植物构建体。 组织移植物构建体包含选自肝基底膜和其提取物及其水解物的基质组合物,以及来自脊椎动物非粘膜下层源的加工胶原,加入的内皮细胞和至少一种另外预选的外源细胞群,其增强 在授权中启动类似船只的结构。 预选的细胞群可以是非角化角化角化细胞或角化细胞上皮细胞群或选自成纤维细胞,平滑肌细胞,骨骼肌细胞,心肌细胞,多潜能祖细胞, 周细胞,成骨细胞和任何其它合适的细胞类型,优选基于待修复的组织选择。 还提供了用于增强这些组织移植物构建体体内血管形成和制备这些移植物构建体的方法。
    • 3. 发明授权
    • Vascularization enhanced graft constructs
    • 血管化增强移植物构建体
    • US07776596B2
    • 2010-08-17
    • US10428358
    • 2003-05-02
    • Stephen F. Badylak
    • Stephen F. Badylak
    • A01N63/00A61K35/22A61K35/37C12N5/00C12N5/08
    • A61L27/3886A61K35/12A61L27/3604A61L27/3804A61L27/3808A61L27/3813A61L27/3826A61L27/383C12N5/0685C12N5/069C12N5/0697C12N2501/135C12N2501/15C12N2501/165C12N2502/1347C12N2502/253C12N2502/28C12N2509/00
    • A tissue graft construct for use in repairing diseased or damaged tissues is provided. The tissue graft construct comprises a matrix composition selected from the group consisting of urinary bladder submucosa and stomach submucosa, and extracts and hydrolysates thereof, added endothelial cells, and at least one additional preselected, exogenous population of cells which enhance initiation of the formation vessel-like structures in the graft construct. The preselected population of cells can be a population of non-keratinized or keratinized epithelial cells or a population of mesodermally-derived cells selected from the group consisting of fibroblasts, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, multi-potential progenitor cells, pericytes, osteogenic cells, and any other suitable cell type, preferably selected based on the tissue to be repaired. Methods for enhancing the vascularization in vivo of these tissue graft constructs and for preparing these graft constructs are also provided.
    • 提供了用于修复患病或受损组织的组织移植物构建体。 组织移植物构建体包含选自膀胱粘膜下层和胃粘膜下层的基质组合物,其提取物和水解物,加入的内皮细胞和至少一种额外的预选的外源细胞群,其增强了形成血管 - 类似结构在移植物构造。 预选的细胞群可以是非角化角化角化细胞或角化细胞上皮细胞群或选自成纤维细胞,平滑肌细胞,骨骼肌细胞,心肌细胞,多潜能祖细胞 ,周细胞,成骨细胞和任何其它合适的细胞类型,优选基于待修复的组织选择。 还提供了用于增强这些组织移植物构建体体内血管形成和制备这些移植物构建体的方法。
    • 5. 发明授权
    • Vascularization enhanced graft constructs
    • US07608454B2
    • 2009-10-27
    • US10428355
    • 2003-05-02
    • Stephen F. Badylak
    • Stephen F. Badylak
    • A61K35/407A61K35/12C12N5/08
    • A tissue graft construct for use in repairing diseased or damaged tissues is provided. The tissue graft construct comprises a matrix composition selected from the group consisting of liver basement membrane and extracts and hydrolysates thereof, and processed collagen from vertebrate non-submucosal sources, added endothelial cells, and at least one additional preselected, exogenous population of cells which enhance the initiation of vessel-like structures in the grant. The preselected population of cells can be a population of non-keratinized or keratinized epithelial cells or a population of mesodermally derived cells selected from the group consisting of fibroblasts, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, multi-potential progenitor cells, pericytes, osteogenic cells, and any other suitable cell type, preferably selected based on the tissue to be repaired. Methods for enhancing the vascularization in vivo of these tissue graft constructs and for preparing these graft constructs are also provided.
    • 7. 发明授权
    • Tubular submucosal graft constructs
    • 管状粘膜下移植物构建体
    • US06187039B1
    • 2001-02-13
    • US09297620
    • 1999-05-04
    • Michael C. HilesUmesh H. PatelLeslie A. GeddesStephen F. Badylak
    • Michael C. HilesUmesh H. PatelLeslie A. GeddesStephen F. Badylak
    • A60F206
    • A61L27/3604A61F2/06A61F2310/00365A61L27/24A61L27/3629A61L27/3687
    • An easy-to-produce and mechanically strong tube of an implantable submucosal tissue has been developed which is manufactured in any desired length, wall thickness, or diameter. The construct produced by the method of the invention may be used as grafts for arteries, veins, ureters, urethras, shunts, or in any application where a compliant, tissue-compatible tube is needed. The manufacture of the submucosal tissue prosthesis generally involves wrapping a first sheet of submucosal tissue (60) and a second sheet of submucosal tissue (70) around a mandrel (50), wherein the first end (74) and the second opposite end (76) of the second sheet of submucosal tissue (70) are sutured together with sutures (78). The submucosal tissue is compressed and dried on the mandrel (50) before removing the construct by pulling on a first end (54) and a second end (56) of a water permeable tape to unwind the tape and thus release the construct for eventual use.
    • 已经开发了可植入的粘膜下组织的容易制造和机械强度的管,其以任何期望的长度,壁厚或直径制造。 通过本发明的方法生产的构造体可以用作动脉,静脉,输尿管,尿道,分流器的移植物,或者在需要顺应的组织相容管的任何应用中。 粘膜下组织假体的制造通常包括围绕心轴(50)缠绕第一片粘膜下组织(60)和第二片粘膜下组织(70),其中第一端(74)和第二相对端(76) )的第二片粘膜下组织(70)与缝合线(78)缝合在一起。 在通过拉动透水性带的第一端(54)和第二端(56)去除构造物之前,在心轴(50)上压缩并干燥粘膜下组织以展开带,并因此释放结构以最终使用 。